{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:44:21Z","timestamp":1780526661417,"version":"3.54.1"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Cisplatin (DDP) resistance remains a major challenge in the treatment\nof lung adenocarcinoma (LUAD). Autophagy is an important mechanism to generate drug resistance. It has been established that COL5A1 has been shown to accelerate LUAD metastasis\nand affect cellular processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We investigated the role of COL5A1 in DDP resistance using the H1299\/DDP and\nA549\/DDP cell lines. Flow cytometry, CCK8, and western blot assays were used to detect apoptosis, cell viability, and autophagy. In addition, upstream miRNAs were screened using bioinformatics methods. MS2-RIP assay and luciferase reporter gene assay were used to validate\nmiRNA interaction with COL5A1. Transfection experiments and western blot experiments were\nperformed to investigate miRNA targeting to COL5A1 and its regulation of autophagy through\nFSTL1. The role of miRNA and COL5A1 in LUAD cisplatin resistance was also verified in\nvivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The down-regulation of COL5A1 significantly reduced the survival and autophagy of\nDDP-resistant cells while enhancing apoptosis. MiR-215-5p was found to be a direct regulator of\nCOL5A1, which affects autophagy through FSTL1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present study demonstrated that miR-215-5p regulated COL5A1 to modulate\nFSTL1 and autophagy, thereby attenuating LUAD resistance to DDP. These findings deepen the\nunderstanding of LUAD pathogenesis and provide potential insights into therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010303045240903053257","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T02:22:32Z","timestamp":1726626152000},"page":"2370-2379","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DDP Induced Cytotoxicity through miR-215-5p\/COL5A1\/FSTL1 Axis to Regulate Autophagy in Lung Adenocarcinoma Cells"],"prefix":"10.2174","volume":"26","author":[{"given":"Xinguo","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Pneumology, Affiliated Hospital 6 of Nantong University, The Yancheng School of Clinical Medicine ofNanjing Medical University, Yancheng Third People's Hospital, 224000, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Affiliated Hospital 6 of Nantong University, The Yancheng School of Clinical Medicine ofNanjing Medical University, Yancheng Third People's Hospital, 224000, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longqiang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Affiliated Hospital 6 of Nantong University, The Yancheng School of Clinical Medicine ofNanjing Medical University, Yancheng Third People's Hospital, 224000, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Affiliated Hospital 6 of Nantong University, The Yancheng School of Clinical Medicine ofNanjing Medical University, Yancheng Third People's Hospital, 224000, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Oncology,Affiliated Hospital 6 of Nantong University, The Yancheng School of Clinical Medicine of Nanjing Medical University,Yancheng Third People's Hospital, 224000, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1080\/21655979.2021.1972078","volume":"12","author":"Song J.","year":"2021","unstructured":"Song J.; Sun Y.; Cao H.; Liu Z.; Xi L.; Dong C.; Yang R.; Shi Y.; A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma. Bioengineered  2021,12(1),5932-5949","journal-title":"Bioengineered"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00262-020-02817-z","volume":"70","author":"Yi M.","year":"2021","unstructured":"Yi M.; Li A.; Zhou L.; Chu Q.; Luo S.; Wu K.; Immune signature-based risk stratification and prediction of immune checkpoint inhibitor\u2019s efficacy for lung adenocarcinoma. Cancer Immunol Immunother  2021,70(6),1705-1719","journal-title":"Cancer Immunol Immunother"},{"key":"ref=3","first-page":"15","volume":"22","author":"Su L.","year":"2022","unstructured":"Su L.; Zhao J.; Su H.; Wang Y.; Huang W.; Jiang X.; Gao S.; CircRNAs in lung adenocarcinoma: Diagnosis and therapy. Curr Gene Ther  2022,22(1),15-22","journal-title":"Curr Gene Ther"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.e375","author":"Kris M.G","year":"2014","unstructured":"Kris M.G; Hellmann M.D; Chaft J.E; Chemotherapy for lung cancers: Here to stay. American Society of Clinical Oncology Educational Book  2014","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"113392","DOI":"10.1016\/j.biopha.2022.113392","volume":"153","author":"Guo S.","year":"2022","unstructured":"Guo S.; Bai X.; Shi S.; Li S.; Liu X.; An H.; Kang X.; Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma. Biomed Pharmacother  2022,153,113392","journal-title":"Biomed Pharmacother"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"Ghosh S.","year":"2019","unstructured":"Ghosh S.; Cisplatin: The first metal based anticancer drug. Bioorg Chem  2019,88,102925","journal-title":"Bioorg Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4161\/auto.6309","volume":"4","author":"Kaushal G.P.","year":"2008","unstructured":"Kaushal G.P.; Kaushal V.; Herzog C.; Yang C.; Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy  2008,4(5),710-712","journal-title":"Autophagy"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1152\/jn.00417.2020","volume":"125","author":"Liang Z.","year":"2021","unstructured":"Liang Z.; Zhang T.; Zhan T.; Cheng G.; Zhang W.; Jia H.; Yang H.; Metformin alleviates cisplatin-induced ototoxicity by autophagy induction possibly via the AMPK\/FOXO3a pathway. J Neurophysiol  2021,125(4),1202-1212","journal-title":"J Neurophysiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6419695","volume":"2022","author":"Zhu H.","year":"2022","unstructured":"Zhu H.; Hu X.; Feng S.; Jian Z.; Xu X.; Gu L.; Xiong X.; The hypoxia-related gene COL5A1 is a prognostic and immunological biomarker for multiple human tumors. Oxid Med Cell Longev  2022,2022,1-42","journal-title":"Oxid Med Cell Longev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/lio2.966","volume":"7","author":"Gong H.","year":"2022","unstructured":"Gong H.; Wu W.; Fang C.; He D.; CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression through miR-31-5p\/COL5A1 axis. Laryngoscope Investig Otolaryngol  2022,7(6),1951-1962","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/CMAR.S188216","volume":"11","author":"Feng G.","year":"2019","unstructured":"Feng G.; Ma H.M.; Huang H.B.; Li Y.W.; Zhang P.; Huang J.J.; Cheng L.; Li G.R.; Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma. Cancer Manag Res  2019,11,1263-1274","journal-title":"Cancer Manag Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"837581","DOI":"10.3389\/fonc.2022.837581","volume":"12","author":"Wang C.","year":"2022","unstructured":"Wang C.; Wang Y.; Fu Z.; Huang W.; Yu Z.; Wang J.; Zheng K.; Zhang S.; Li S.; Chen J.; MiR-29b-3p inhibits migration and invasion of papillary thyroid carcinoma by downregulating COL1A1 and COL5A1. Front Oncol  2022,12,837581","journal-title":"Front Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s12033-022-00491-3","volume":"64","author":"Chakraborty S.","year":"2022","unstructured":"Chakraborty S.; Nath D.; A study on micrornas targeting the genes overexpressed in lung cancer and their codon usage patterns. Mol Biotechnol  2022,64(10),1095-1119","journal-title":"Mol Biotechnol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gene.2018.04.066","volume":"665","author":"Liu W.","year":"2018","unstructured":"Liu W.; Wei H.; Gao Z.; Chen G.; Liu Y.; Gao X.; Bai G.; He S.; Liu T.; Xu W.; Yang X.; Jiao J.; Xiao J.; COL5A1 may contribute the metastasis of lung adenocarcinoma. Gene  2018,665,57-66","journal-title":"Gene"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.7150\/thno.44877","volume":"10","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Zhou Y.; Han F.; Zhao Y.; Tu M.; Wang Y.; Huang C.; Fan S.; Chen P.; Yao X.; Guan L.; Yu A.M.; Gonzalez F.J.; Huang M.; Bi H.; A novel miR-1291-ERR\u03b1-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Theranostics  2020,10(16),7193-7210","journal-title":"Theranostics"},{"key":"ref=16","first-page":"8640","volume":"22","author":"Sun F.B.","year":"2018","unstructured":"Sun F.B.; Lin Y.; Li S.J.; Gao J.; Han B.; Zhang C.S.; MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression. Eur Rev Med Pharmacol Sci  2018,22(24),8640-8648","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1080\/21655979.2021.2001989","volume":"12","author":"Cai Y.","year":"2021","unstructured":"Cai Y.; An B.; Yao D.; Zhou H.; Zhu J.; MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy. Bioengineered  2021,12(2),10713-10722","journal-title":"Bioengineered"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","volume":"27","author":"Singh A.","year":"2019","unstructured":"Singh A.; Bhattacharyya N.; Srivastava A.; Pruett N.; Ripley R.T.; Schrump D.S.; Hoang C.D.; MicroRNA-215-5p treatment suppresses mesothelioma progression via the mdm2-p53-signaling axis. Mol Ther  2019,27(9),1665-1680","journal-title":"Mol Ther"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/2211-5463.12733","volume":"9","author":"Gao J.B.","year":"2019","unstructured":"Gao J.B.; Zhu M.N.; Zhu X.L.; miRNA\u2010215\u20105p suppresses the aggressiveness of breast cancer cells by targeting Sox9. FEBS Open Bio  2019,9(11),1957-1967","journal-title":"FEBS Open Bio"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41389-017-0006-6","volume":"6","author":"Vychytilova-Faltejskova P.","year":"2017","unstructured":"Vychytilova-Faltejskova P.; Merhautova J.; Machackova T.; Gutierrez-Garcia I.; Garcia-Solano J.; Radova L.; Brchnelova D.; Slaba K.; Svoboda M.; Halamkova J.; Demlova R.; Kiss I.; Vyzula R.; Conesa-Zamora P.; Slaby O.; MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis  2017,6(11),399","journal-title":"Oncogenesis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/ijms20071611","volume":"20","author":"Wu K.L.","year":"2019","unstructured":"Wu K.L.; Tsai Y.M.; Lien C.T.; Kuo P.L.; Hung J.Y.; The roles of MicroRNA in lung cancer. Int J Mol Sci  2019,20(7),1611","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00280-020-04215-9","volume":"87","author":"Liu Y.K.","year":"2021","unstructured":"Liu Y.K.; Jia Y.J.; Liu S.H.; Ma J.; FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-\u03baB pathway. Cancer Chemother Pharmacol  2021,87(3),405-414","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/CBM-170132","volume":"20","author":"Yang W.","year":"2017","unstructured":"Yang W.; Wu Y.; Wang C.; Liu Z.; Xu M.; Zheng X.; FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT\/GSK-3\u03b2 \u2013 dependent manner in hepatocellular carcinoma. Cancer Biomark  2017,20(1),75-85","journal-title":"Cancer Biomark"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1089\/cbr.2019.3046","volume":"35","author":"Jin T.","year":"2020","unstructured":"Jin T.; Zhang Y.; Zhang T.; MiR-524-5p suppresses migration, invasion, and emt progression in breast cancer cells through targeting FSTL1. Cancer Biother Radiopharm  2020,35(10),789-801","journal-title":"Cancer Biother Radiopharm"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"18076","DOI":"10.18632\/oncotarget.6729","volume":"7","author":"Bae K.","year":"2016","unstructured":"Bae K.; Park K.E.; Han J.; Kim J.; Kim K.; Yoon K.A.; Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1\/2 in human lung cancer cells. Oncotarget  2016,7(14),18076-18084","journal-title":"Oncotarget"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.3390\/cancers14133244","volume":"14","author":"Yang M.","year":"2022","unstructured":"Yang M.; Lu Z.; Yu B.; Zhao J.; Li L.; Zhu K.; Ma M.; Long F.; Wu R.; Hu G.; Huang L.; Chou J.; Gong N.; Yang K.; Li X.; Zhang Y.; Lin C.; COL5A1 Promotes the progression of gastric cancer by acting as a cerna of mir-137-3p to upregulate FSTL1 expression. Cancers  2022,14(13),3244","journal-title":"Cancers"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41419-022-04908-4","volume":"13","author":"Shi L.","year":"2022","unstructured":"Shi L.; Cao Y.; Yuan W.; Guo J.; Sun G.; Exosomal circRNA BTG2 derived from RBP-J overexpressed-macrophages inhibits glioma progression via miR-25-3p\/PTEN. Cell Death Dis  2022,13(5),506","journal-title":"Cell Death Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"Kim J.","year":"2011","unstructured":"Kim J.; Kundu M.; Viollet B.; Guan K.L.; AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol  2011,13(2),132-141","journal-title":"Nat Cell Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3955748","volume":"2022","author":"Xie X.","year":"2022","unstructured":"Xie X.; Li D.; Cui Y.; Xie T.; Cai J.; Yao Y.; Decorin protects retinal pigment epithelium cells from oxidative stress and apoptosis via AMPK-mTOR-regulated autophagy. Oxid Med Cell Longev  2022,2022,1-17","journal-title":"Oxid Med Cell Longev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41419-019-1699-6","volume":"10","author":"Wu X.","year":"2019","unstructured":"Wu X.; Xiao Y.; Zhou Y.; Zhou Z.; Yan W.; LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death Dis  2019,10(7),472","journal-title":"Cell Death Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-020-01284-x","volume":"20","author":"Wang H.","year":"2020","unstructured":"Wang H.; Chen J.; Zhang S.; Zheng X.; Xie S.; Mao J.; Cai Y.; Lu X.; Hu L.; Shen J.; Chai K.; Chen W.; MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer. Cancer Cell Int  2020,20(1),258","journal-title":"Cancer Cell Int"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3892\/ijo.2019.4725","volume":"54","author":"Piotrowska A.","year":"2019","unstructured":"Piotrowska A.; Wierzbicka J.; Rybarczyk A.; Tuckey R.; Slominski A.; \u017bmijewski M.; Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line. Int J Oncol  2019,54(4),1481-1495","journal-title":"Int J Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.7150\/jca.21267","volume":"8","author":"Zang H.","year":"2017","unstructured":"Zang H.; Peng J.; Wang W.; Fan S.; Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer. J Cancer  2017,8(18),3856-3861","journal-title":"J Cancer"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3390\/ijms19051405","volume":"19","author":"Islam M.A.","year":"2018","unstructured":"Islam M.A.; Sooro M.A.; Zhang P.; Autophagic regulation of p62 is critical for cancer therapy. Int J Mol Sci  2018,19(5),1405","journal-title":"Int J Mol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41419-022-04727-7","volume":"13","author":"Tantai J.","year":"2022","unstructured":"Tantai J.; Pan X.; Chen Y.; Shen Y.; Ji C.; TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death Dis  2022,13(3),285","journal-title":"Cell Death Dis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/1759-7714.13558","volume":"11","author":"Du H.","year":"2020","unstructured":"Du H.; Li Y.; Sun R.; Yuan Y.; Sun S.; Zhang Y.; CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a. Thorac Cancer  2020,11(9),2473-2482","journal-title":"Thorac Cancer"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.drup.2023.100933","volume":"68","author":"Zhu C.","year":"2023","unstructured":"Zhu C.; Xie Y.; Li Q.; Zhang Z.; Chen J.; Zhang K.; Xia X.; Yu D.; Chen D.; Yu Z.; Chen J.; CPSF6-mediated XBP1 3\u2019UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma. Drug Resist Updat  2023,68,100933","journal-title":"Drug Resist Updat"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12539-015-0117-8","volume":"8","author":"Ma R.","year":"2016","unstructured":"Ma R.; Wang C.; Wang J.; Wang D.; Xu J.; miRNA\u2013mRNA interaction network in non-small cell lung cancer. Interdiscip Sci  2016,8(3),209-219","journal-title":"Interdiscip Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1111\/jcmm.16402","volume":"25","author":"Wang M.","year":"2021","unstructured":"Wang M.; Liao J.; Tan C.; Zhou H.; Wang J.; Wang K.; Li Y.; Wu W.; Integrated study of miR\u2010215 promoting breast cancer cell apoptosis by targeting RAD54B. J Cell Mol Med  2021,25(7),3327-3338","journal-title":"J Cell Mol Med"},{"key":"ref=40","first-page":"483","volume":"10","author":"Zhao J.","year":"2018","unstructured":"Zhao J.; Xu J.; Zhang R.; SRPX2 regulates colon cancer cell metabolism by miR-192\/215 via PI3K-Akt. Am J Transl Res  2018,10(2),483-490","journal-title":"Am J Transl Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9537382","volume":"2019","author":"Yang W.","year":"2019","unstructured":"Yang W.; Duan Q.; Zhu X.; Tao K.; Dong A.; Follistatin-like 1 attenuates ischemia\/reperfusion injury in cardiomyocytes via regulation of autophagy. BioMed Res Int  2019,2019,1-8","journal-title":"BioMed Res Int"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"L27","DOI":"10.1152\/ajplung.00510.2016","volume":"313","author":"Liu T.","year":"2017","unstructured":"Liu T.; Liu Y.; Miller M.; Cao L.; Zhao J.; Wu J.; Wang J.; Liu L.; Li S.; Zou M.; Xu J.; Broide D.H.; Dong L.; Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma. Am J Physiol Lung Cell Mol Physiol  2017,313(1),L27-L40","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010303045240903053257","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234126\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010303045240903053257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:08:23Z","timestamp":1764324503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234126\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010303045240903053257","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}